7 May 2024
Anjarium Biosciences Presents Data Demonstrating Novel Synthetic DNA Applications for Cell and Gene Therapies at 27th Annual ASGCT Meeting
8 December 2022
Anjarium Biosciences appoints Chief Technology Officer
18 October 2022
Anjarium Biosciences appoints Chairperson and Non-executive Director
12 July 2022
Anjarium Biosciences appoints experienced industry executives
14 June 2022
Anjarium Biosciences appoints Chief Executive Officer
16 September 2021
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing
May 2024
Visit us at ASGCT, Booth #312
7-11 May, 2024
ASGCT | Baltimore, MD
October 2024
Visit with us at Cell & Gene Meeting on the Mesa
7-9 October, 2024
Meeting on the Mesa | Phoenix, AZ
October 2024
Visit us at ESGCT
22-25 October, 2024
ESGCT | Rome, Italy
